Health At Every Size and Acceptance and Commitment Therapy vs. Behavioral Weight Loss for Obesity and Depression in Women
Health At Every Size and Acceptance and Commitment Therapy vs. Behavioral Weight Loss for Obesity and Depression in Women: A Randomized Controlled Trial
Studieöversikt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Studietyp
Studietyp
Inskrivning (Faktisk)
Inskrivning
Fas
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
New Hampshire
-
Lebanon, New Hampshire, Förenta staterna, 03766
- Dartmouth-Hitchcock Medical Center
-
-
Deltagandekriterier
Urvalskriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- English-speaking
- Major Depressive Disorder (assessed using the Structured Clinical Interview for DSM-IV, SCID-IV)
- Body Mass Index (BMI) greater than or equal to 30
- Not taking medications or on stable medication regimens (i.e. no medication changes for six weeks prior to enrollment or during the study)
Exclusion Criteria:
- current substance dependence
- history of psychotic symptoms
- high risk of suicide/self-harm
- current enrollment in a weight-loss program
- weight loss surgery in the past year
- current psychotherapy
- inability to postpone weight loss or depression treatment interventions for the duration of the study
- taking antipsychotic, tricyclic, or oral corticosteroid medication
- unwilling to be randomized to the study treatments
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Antal vapen
Vapen och interventioner
Deltagargrupp / ArmDeltagargrupp / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Experimentell: Accept Yourself! Intervention
Combined Health At Every Size and Acceptance and Commitment Therapy Psychotherapy Group
|
Andra namn:
|
|
Aktiv komparator: Behavioral Weight Loss
Weight Watchers groups
|
Vad mäter studien?
Primära resultatmått
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in clinician assessed depression symptoms
Tidsram: At post-treatment (immediately following the three-month intervention) and at 3, 6, 9, and 12-month follow-up assessments.
|
As assessed by clinician rated Hamilton Depression Rating Scale (HAM-D)
|
At post-treatment (immediately following the three-month intervention) and at 3, 6, 9, and 12-month follow-up assessments.
|
|
Change in self-reported depression symptoms
Tidsram: At post-treatment (immediately following the three-month intervention) and at 3, 6, 9, and 12-month follow-up assessments.
|
As assessed by Patient Health Questionnaire-9 (PHQ-9)
|
At post-treatment (immediately following the three-month intervention) and at 3, 6, 9, and 12-month follow-up assessments.
|
Sekundära resultatmått
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in fasting Lipids
Tidsram: At post-treatment (immediately following the three-month intervention) and at 12 month follow-up.
|
At post-treatment (immediately following the three-month intervention) and at 12 month follow-up.
|
|
|
Change in systolic and diastolic blood pressure
Tidsram: At post-treatment (immediately following the three-month intervention) and 12 month follow up
|
At post-treatment (immediately following the three-month intervention) and 12 month follow up
|
|
|
Change in fasting blood glucose
Tidsram: At post-treatment (immediately following the three-month intervention) and 12 month follow up
|
At post-treatment (immediately following the three-month intervention) and 12 month follow up
|
|
|
Change in eating disorder symptoms, measured by the Eating Disorders Diagnostic Scale (EDDS)
Tidsram: At post-treatment (immediately following the three-month intervention) and at 3, 6, 9, and 12-month assessments.
|
At post-treatment (immediately following the three-month intervention) and at 3, 6, 9, and 12-month assessments.
|
|
|
Change in obesity-related quality of life, measured by the Obesity-Related Well-Being Questionnaire (ORWELL97)
Tidsram: At post-treatment (immediately following the three-month intervention) and at 3, 6, 9, and 12-month assessments.
|
At post-treatment (immediately following the three-month intervention) and at 3, 6, 9, and 12-month assessments.
|
|
|
Change in obesity stigma, measured by the Weight Self-Stigma Questionnaire (WSSQ)
Tidsram: At post-treatment (immediately following the three-month intervention) and at 3, 6, 9, and 12-month assessments.
|
At post-treatment (immediately following the three-month intervention) and at 3, 6, 9, and 12-month assessments.
|
|
|
Number of participants who did not complete an adequate dose of the intervention (at least 7 group visits)
Tidsram: At post-treatment (immediately following the three-month intervention)
|
At post-treatment (immediately following the three-month intervention)
|
|
|
Change in weight
Tidsram: At post-treatment (immediately following the three-month intervention) and 12 month follow up
|
Note that we are assessing weight change primarily as a safety measure (i.e., to demonstrate no significant weight gain in intervention group).
|
At post-treatment (immediately following the three-month intervention) and 12 month follow up
|
|
Change in self-reported physical activity
Tidsram: At post-treatment (immediately following the three-month intervention) and at 12-month follow-up.
|
At post-treatment (immediately following the three-month intervention) and at 12-month follow-up.
|
|
|
Change in cardiovascular fitness as assessed by six-minute walk test
Tidsram: At post-treatment (immediately following the three-month intervention) and at 12-month follow-up.
|
At post-treatment (immediately following the three-month intervention) and at 12-month follow-up.
|
Samarbetspartners och utredare
Sponsor
Sponsor
Samarbetspartners
Samarbetspartners
Utredare
Utredare
- Huvudutredare: Margit I Berman, Ph.D, Dartmouth College
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Studiestart
Primärt slutförande (Faktisk)
Primärt slutförande
Avslutad studie (Faktisk)
Avslutad studie
Studieregistreringsdatum
Först inskickad
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Första postat
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste uppdatering publicerad
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
Andra studie-ID-nummer
- D15151
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
produkt tillverkad i och exporterad från U.S.A.
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .